MedTrace Logo

Pharmacists Expand Access to Reproductive heaLthcare

NCT03830567 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 471

Last updated 2024-04-04

No results posted yet for this study

Summary

Prospective cohort study of women presenting to initiate hormonal contraception, prescribed by a clinician or pharmacist. Women will be followed for one year to assess contraceptive continuation and unintended pregnancy rates, as well as measures of safety and acceptability.

Conditions

  • Contraception

Interventions

OTHER

Pharmacist prescription

Pharmacist prescribed hormonal contraception (initiation or continuation).

OTHER

Clinician prescription

Clinician prescribed hormonal contraception (initiation or continuation).

Sponsors & Collaborators

  • Laura and John Arnold Foundation

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Principal Investigators

  • Maria I Rodriguez, MD, MPH · Oregon Health and Science University

Eligibility

Min Age
18 Years
Max Age
51 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-27
Primary Completion
2021-02-02
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03830567 on ClinicalTrials.gov